On Wednesday, Synchrony Financial (NYSE:SYF*)’s shares declined -1.11% to $32.08.
SYF has 97.30% institutional ownership while its EPS ratio was 2.63. The company market capitalization of the company was $26.75 billion. Price to book ratio was 2.20. Net profit margin of the company was 16.90%. Stock volatility for the month was booked as 3.06% while for the week was recorded as 3.44%.
The mean estimate for the short term price target for Synchrony Financial (SYF) stands at $38.50 according to 21 Analysts. The higher price target estimate for the stock has been calculated at $42.00 while the lower price target estimate is at $30.00.
Analysts mean recommendation for the stock is 1.90. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Synchrony Financial operates as a consumer financial services company in the United States. The company offers private label credit cards, dual cards, and small and medium-sized business credit products; and promotional financing for consumer purchases, such as private label credit cards and installment loans.
HCP, Inc. (NYSE:HCP)’s shares gained -1.72% to $36.10.
HCP has the market capitalization of $16.98 billion. The stock has P/B ratio of 1.63 while EPS was $0.51. Institutional ownership of the company was 89.30% while 465.04 million shares were outstanding. Net profit margin of the Company was 15.20% while its gross profit margin was 79.40%. Share of the company moved below its SMA 50 with -4.61%. ROE ratio was 3.50% while ROI was 6.50%.
The mean estimate for the short term price target for HCP, Inc. (HCP) stands at $40.15 according to 13 Analysts. The higher price target estimate for the stock has been calculated at $44.00 while the lower price target estimate is at $37.00.
Analysts mean recommendation for the stock is 2.90. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
HCP, Inc. (HCP) is a real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio comprises of investments in various healthcare segments: senior housing, post-acute/skilled nursing, life science, medical office and hospital.
At the end of Wednesday’s trade, Credit Suisse Group AG (ADR) (NYSE:CS)‘s shares dipped -0.85% to $24.38.
CS Its past 5-day performance at -1.89%. So far in 2015, the company has a year-to-date performance of -2.79%. The stock, as of last close, traded 19.09% up from its 52 week low and was -18.71% below its 52 week high. Its latest closing price was -6.22% above the SMA200 while the distance from SMA 50 and SMA 20 was -4.35% and -2.81% respectively.
The mean estimate for the short term price target for Credit Suisse Group AG (ADR) (CS) stands at $23.00 according to 1 Analysts. The higher price target estimate for the stock has been calculated at $23.00 while the lower price target estimate is at $23.00.
Analysts mean recommendation for the stock is -4.00. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Credit Suisse Group AG (Credit Suisse) is a global financial services company. The Company operates in three segments: Private Banking & Wealth Administration and Investment Banking.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.